March 20 (Reuters) - Australian Clinical Labs Ltd (ACL) :
- ANNOUNCES ITS INTENTION TO MAKE AN OFF-MARKET TAKEOVER OFFER TO ACQUIRE HEALIUS LIMITED
- OFFER WILL BE MADE BY WAY OF AN OFF-MARKET TAKEOVER OFFER BY ACL TO ACQUIRE ALL OF HEALIUS SHARES ON ISSUE
- ACL'S OFFER IS 0.74 ACL SHARES FOR EVERY 1 HEALIUS SHARE HELD
- IF ACL SUCCESSFUL IN ACQUIRING ALL OF HEALIUS SHARES ON ISSUE UNDER OFFER, HEALIUS SHAREHOLDERS WILL HOLD ABOUT 68% OF ACL
- ACL EXPECTS THAT ITS EBIT FOR FY23 WILL BE WITHIN RANGE OF A$68 MILLION AND A$74 MILLION
- MATERIAL SYNERGY POTENTIAL OF A$95 MILLION BY BRINGING COMPANIES TOGETHER
- POTENTIAL MERGED GROUP PRO FORMA FY23 EBIT OF A$361 MILLION INCLUDING EXPECTED COST SYNERGIES
(([email protected];))
News: ACL Australian Clinical Labs Intends To Make Off-Market Takeover Offer To Acquire Healius
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.83 |
Change
0.000(0.00%) |
Mkt cap ! $555.7M | |||
| Open | High | Low | Value | Volume |
| $2.85 | $2.86 | $2.81 | $4.431M | 1.570M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 25431 | $2.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.86 | 11164 | 3 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| ACL (ASX) Chart |